Gp Pharm S.A.U
Spain Updated 9 July 2026
The public registers hold a second record for Gp Pharm S.A.U. The fuller profile,
with 0 active US DMFs and 0 valid CEPs, is at Gp Pharm.
Figures on this page cover only this record.
Gp Pharm S.A.U is a contract manufacturer based in Spain. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 21 September 2023 as VAI.
1
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 21 September 2023 VAI US FDA
- 2 October 2020 VAI US FDA
- 27 January 2015 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Spain, Spain | 3008345811 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Gp Pharm S.A.U comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 21 September 2023.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates